Secondary cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves overall survival in ...

Mirvetuximab soravtansine (MIRV; Elahere; AbbVie) demonstrated significant efficacy and an acceptable safety profile in the treatment of recurrent ovarian cancer, showing particular promise in ...

First-line PARP inhibitor maintenance after platinum chemotherapy reduces progression risk in certain patients with ovarian ...

Fertility preservation plays a crucial role for those with cancer. Learn how it can secure reproductive options amid ...